Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β

Amir S. Yazdi, Greta Guarda, Nicolas Riteau, Stefan K. Drexler, Aubry Tardivel, Isabelle Couillin, Jürg Tschopp

Proceedings of the National Academy of Sciences · 2010 · 517 citations · 29 references

Concepts

TL;DR

Nanoparticles, especially TiO₂ used as cosmetic pigments, are increasingly common, yet emerging evidence links TiO₂ exposure to respiratory disease. Nano‑TiO₂ (and nano‑SiO₂) activates the NLRP3 inflammasome, triggering IL‑1α/β release without phagocytosis, and inhalation provokes IL‑1R‑dependent lung inflammation that is largely driven by IL‑1α, raising concerns comparable to asbestos exposure.

Abstract

Nanoparticles are increasingly used in various fields, including biomedicine and electronics. One application utilizes the opacifying effect of nano-TiO 2 , which is frequently used as pigment in cosmetics. Although TiO 2 is believed to be biologically inert, an emerging literature reports increased incidence of respiratory diseases in people exposed to TiO 2 . Here, we show that nano-TiO 2 and nano-SiO 2 , but not nano-ZnO, activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome, leading to IL-1β release and in addition, induce the regulated release of IL-1α. Unlike other particulate Nlrp3 agonists, nano-TiO 2 –dependent-Nlrp3 activity does not require cytoskeleton-dependent phagocytosis and induces IL-1α/β secretion in nonphagocytic keratinocytes. Inhalation of nano-TiO 2 provokes lung inflammation which is strongly suppressed in IL-1R– and IL-1α–deficient mice. Thus, the inflammation caused by nano-TiO 2 in vivo is largely caused by the biological effect of IL-1α. The current use of nano-TiO 2 may present a health hazard due to its capacity to induce IL-1R signaling, a situation reminiscent of inflammation provoked by asbestos exposure.

References

29